EB THERAPEUTICS LTD
Significant control: Cure Eb (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Eb Therapeutics Ltd: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
What does Eb Therapeutics Ltd sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
EB THERAPEUTICS LTD is an active private limited company (company number 11733305) incorporated on 18 December 2018, registered in London. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 31 December 2024 and cash of £178k, with 4 employees on average.
There are 603 companies in research and experimental development on biotechnology in London with filed accounts; the median reports net assets of £440 and is 6 years old.
Ownership and control
- Cure Eb
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 18 December 20187 yrs ago
- Next accounts due
- 30 September 202624 days overdue
- Confirmation statement due
- 1 January 2027in 69 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72110
- Research and experimental development on biotechnology
- SIC 86900
- Other human health activities
- SIC 96090
- Other service activities n.e.c.
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 December 2024 | — | £178k | £66k | £243k | — | — | 4 |
| 31 December 2023 | — | £23k | £100 | £23k | — | — | 4 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
Filing and accounts signals
- Cash at bank of £50,000 or moreCash £177,505
- Incorporated five or more years agoIncorporated 18 December 2018
- Accounts past their due dateDue 30 September 2026
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Confirmation statement duein 69 days
- Next accounts due24 days overdue
- Accounts period end
- Accounts period end
- Incorporated
Similar companies in London
Reminders for EB THERAPEUTICS LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.